🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of mu...
Status
Completed
Location
Multiple Locations
Start Date
2008-03
Trial ID
NCT00677053
This study aims to analyze changes in the immune status, metabolic status, ...
Status
Not Yet Recruiting
Location
First Affiliated Hospital of Xian Jiantong University
Start Date
2024-12-31
Trial ID
NCT06141538
Treatments Being Tested
This is a multi-center, prospective, open-label, randomized controlled tria...
Status
Not Yet Recruiting
Location
Fuwai Hospital
Start Date
2026-05-26
Trial ID
NCT07616414
Treatments Being Tested
The investigators aimed to verify the efficacy and safety of nadroparin cal...
Status
Completed
Location
Department of Gastroenterology,Qilu Hospital,Shandong University
Start Date
2020-02-01
Trial ID
NCT04976543
Treatments Being Tested
The central questions of the study can be summarized as follows: What stro...
Status
Completed
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02657616
Treatments Being Tested
Oral anticoagulants (OACs - warfarin, dabigatran, rivaroxaban, apixaban and...
Status
Completed
Location
St Joseph's Healthcare Hamilton
Start Date
2020-12-16
Trial ID
NCT02777047
Treatments Being Tested
The purpose of this study is to determine if TAK-442, once daily (QD) or tw...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00641732
Atrial fibrillation (irregular heartbeat) increases the risk of stroke, and...
Status
Enrolling By Invitation
Location
National Taiwan University Hospital
Start Date
2025-03-05
Trial ID
NCT07159399
Treatments Being Tested
The purpose of study was to test whether rivaroxaban added to standard of c...
Status
Completed
Location
Multiple Locations
Start Date
2015-08-18
Trial ID
NCT02504216
Treatments Being Tested
Rationale: According to the latest National Survey on Care-Related Adverse...
Status
Recruiting
Location
CHU Besançon
Start Date
2021-01-01
Trial ID
NCT06692504